Avik Pharmaceuticals

Mumbai, India Founded: 1980 • Age: 46 yrs
Manufactures corticosteroids and steroid APIs for pharmaceutical industry.
Annual revenue $9.7M Latest available
Total funding - Funding intelligence
Employees 174 Tracked headcount
Investors - Known backers
Products 6 Services tracked
Competitors 9 Brand Intelligence

About Avik Pharmaceuticals

Avik Pharmaceuticals is a company based in Mumbai (India) founded in 1980 by Anant Thakore. It operates as a B2B. The company has 174 employees as of March 31, 2023. Avik Pharmaceuticals offers products and services including Beclomethasone Dipropionate, Betamethasone Dipropionate, Budesonide, Clobetasol 17 Propionate, and Testosterone. Avik Pharmaceuticals operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

  • Headquarter Mumbai, India
  • Employees 174 as on 31 Mar, 2023
  • Founders Anant Thakore
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Avik Pharmaceutical Limited
  • Date of Incorporation 25 Sep, 1979
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $9.67 M (USD)
    25.22
    as on Mar 31, 2023
  • Net Profit
    $629.06 K (USD)
    49.19
    as on Mar 31, 2023
  • EBITDA
    $1.07 M (USD)
    28.5
    as on Mar 31, 2023
  • Latest Funding Round
  • Investors
  • Employee Count
    174

    as on Mar 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Avik Pharmaceuticals

Avik Pharmaceuticals offers a comprehensive portfolio of products and services, including Beclomethasone Dipropionate, Betamethasone Dipropionate, Budesonide, Clobetasol 17 Propionate, and Testosterone.

Primary

Corticosteroid API used in respiratory treatments.

Anti-inflammatory steroid for skin conditions.

Corticosteroid for asthma and allergy management.

Topical steroid for severe skin inflammation.

Steroidal hormone for medical hormone therapy.

Progestin used in contraceptives and treatments.

Funding Insights of Avik Pharmaceuticals

Investments & Acquisitions by Avik Pharmaceuticals

Investments

Financial Statements - Avik Pharmaceuticals

Avik Pharmaceuticals Comparisons

+
Add Comparison
Available on Premium

Competitors of Avik Pharmaceuticals

Avik Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceutical and biotechnology company
domain founded_year HQ Location
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
domain founded_year HQ Location
APIs and drug products are developed and valorized in pharmaceuticals.
domain founded_year HQ Location
APIs, intermediates, and biochemical reagents are developed and manufactured.
domain founded_year HQ Location
APIs are developed and manufactured for therapeutic areas.
domain founded_year HQ Location
Contract development, manufacturing, and analytical services for APIs are offered.

Latest news on Avik Pharmaceuticals

Frequently Asked Questions about Avik Pharmaceuticals

Avik Pharmaceuticals was founded in 1980.

Avik Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Anant Thakore is the current CEO of Avik Pharmaceuticals. They have also founded this company.

As of Mar 31, 2023, the latest employee count at Avik Pharmaceuticals is 174.

Annual revenue of Avik Pharmaceuticals is $9.67M as on Mar 31, 2023.

Avik Pharmaceutical Limited is an RD-based company specializing in the production of active pharmaceutical ingredients, primarily corticosteroids, since the 1980s. It operates manufacturing facilities in Vapi, Gujarat, near Mumbai, India, focusing on steroids and hormones. The company supplies these products to various pharmaceutical entities, emphasizing quality and innovation in API development.

Avik Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.

Avik Pharmaceuticals offers Beclomethasone Dipropionate, Betamethasone Dipropionate, Budesonide, Clobetasol 17 Propionate, and 2 more products and services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available